Molecular mechanisms of low-density lipoprotein receptor regulation by the protease BMP1
Molecular mechanisms of low-density lipoprotein receptor regulation by the protease BMP1
批准号:
2761362
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cholesterol homeostasis in mammals is tightly controlled by its biosynthesis, dietary intake and cellular uptake from the blood. The low-density lipoprotein receptor (LDLR) is responsible for the cellular uptake of cholesterol in the form of low-density lipoprotein cholesterol (LDL-C). At the surface of hepatocytes and other cells, LDLR binds LDL-C and the complex is then internalized by receptor-mediated endocytosis. The activity of LDLR is tightly regulated through its biosynthesis, surface localisation, internalisation, recycling and degradation, in order to maintain cellular cholesterol homeostasis. Recently we have identified that LDLR is proteolytically cleaved at a physiologically-relevant site within its ligand-binding domain by the zinc metalloprotease bone morphogenetic protein 1 (BMP1) (Banerjee et al. 2019). The cleavage of LDLR by BMP1 reduces the binding and endocytosis of LDL-C. Thus proteolytic cleavage of LDLR by BMP1 is a new mechanism to regulate cellular LDL-C uptake. We hypothesise that molecular interactions between BMP1, LDLR and other cellular components regulate the proteolytic cleavage of LDLR by BMP1 and impact on LDL-C metabolism. To address this hypothesis, the objectives of this proposal are to: 1) determine the role of the non-catalytic protein-protein interaction domains on BMP1 in the recognition and cleavage of LDLR; and 2) identify the proteins that bind BMP1 or LDLR to regulate the proteolytic cleavage of LDLR by BMP1 and hence LDL-C endocytosis. This is a curiosity-driven bioscience project that will provide new understanding of the biological mechanisms controlling the cellular uptake of cholesterol and could lead to new molecular targets to modulate low-density lipoprotein receptor (LDLR) action and manage cholesterol homeostasis. Thus, the project addresses the BBSRC priority areas of "Understanding the rules of life" within the "Advancing the frontiers of bioscience discovery" theme.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
-
批准号:--
-
项目类别:外国学者研究基金
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI Z
-
依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
-
批准号:W2433169
-
项目类别:外国学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI ZHANG
-
依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
-
批准号:82371255
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:曹立
-
依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
-
批准号:82370979
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张善勇
-
依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
-
批准号:82370981
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:陈敏洁
-
依托单位:
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
-
批准号:82370851
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:包玉倩
-
依托单位:
小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
-
批准号:82371248
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:吴逸雯
-
依托单位:
用于小尺寸管道高分辨成像荧光聚合物点的构建、成像机制及应用研究
-
批准号:82372015
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:熊丽琴
-
依托单位:
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
-
批准号:82371973
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:孙迪
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位: